Related Experiment Video
Updated: Jun 21, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Childhood hypo-adiponectinaemia but not hyper-leptinaemia is associated with insulin insensitivity 6 years later
Iben Kynde1, Berit Lilienthal Heitmann, Ib Christian Bygbjerg
1Department of Biomedical Sciences, Centre for Healthy Ageing, University of Copenhagen, DK-2200, Copenhagen N, Denmark. ibenk@mfi.ku.dk
Insights
Childhood low adiponectin predicts adolescent insulin insensitivity, especially in overweight children. High leptin indicated current insulin insensitivity but not future risk.
Area of Science:
- Pediatric endocrinology
- Metabolic health research
- Diabetes risk assessment
Background:
- Metabolic and inflammation biomarkers may indicate increased diabetes risk in children.
- Childhood metabolic markers are crucial for predicting long-term health outcomes.
Purpose of the Study:
- To investigate plasma adiponectin, leptin, IL-8, and hepatocyte growth factor (HGF) in children.
- To determine their independent associations with insulin insensitivity, both cross-sectionally and prospectively over 6 years.
Main Methods:
- Utilized data from the European Youth Heart Studies I and II (Danish children aged 8-10 and 14-16).
- Employed cross-sectional and prospective linear regressions analyzing plasma biomarkers and insulin insensitivity (HOMA Z-scores).
- Adjusted for multiple covariates including BMI, physical activity, and sexual maturity.
Main Results:
- Lower baseline adiponectin was linked to insulin insensitivity 6 years later, particularly in overweight children.
- Higher baseline leptin correlated with concurrent insulin insensitivity in younger children but not prospectively.
- No significant associations were found for IL-8 or HGF.
Conclusions:
- Childhood hypo-adiponectinaemia is directly associated with adolescent insulin insensitivity, with a stronger effect in overweight youth.
- Hyper-leptinaemia in childhood is linked to current insulin insensitivity but does not predict future risk.
- These findings highlight adiponectin as a key predictor of future metabolic dysfunction in children.
Background:
Biomarkers of metabolism and inflammation may predict children with increased diabetes risk.
Objective:
To study plasma adiponectin, leptin, IL-8, and hepatocyte growth factor (HGF) in childhood and their independent associations with insulin insensitivity, cross-sectional and in 6-yr prospective.
Subjects:
Danish 8- to 10-yr-olds and 14- to 16-yr-olds from the European Youth Heart Studies I and II.
Methods:
Cross-sectional (n = 386) and prospective (n = 246) linear regressions of baseline concentrations of plasma biomarkers and insulin insensitivity at baseline and 6 yr later. Adjustments were made at four progressive steps for sex, sexual maturity, body mass index (BMI), other biomarkers, physical activity, and school location as well as baseline insulin insensitivity in prospective analyses. Insulin insensitivity was measured using homeostasis model assessment standardized to the sample mean [homoestasis model assessment (HOMA) Z-scores]. Plasma biomarkers were quantified using solid-phase protein immunoassays. Overweight was defined as the highest BMI tertile.
Results:
Among overweight but not lean children at baseline, one SD difference in baseline plasma adiponectin was associated with -0.41 SD difference in HOMA Z-scores 6 yr later (p = 0.006). At baseline, one SD difference in plasma leptin was associated with 0.36 SD difference in HOMA Z-scores (p =< 0.0001) among 8- to 10-yr-olds, but a prospective association was not found.
Conclusions:
We found a direct relationship between childhood hypo-adiponectinaemia and insulin insensitivity in adolescence. This association was stronger for overweight than for normal weight children. Hyper-leptinaemia was associated with concurrent insulin insensitivity at baseline but not 6 yr later.
Related Concept Videos
Obesity
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes I: Introduction
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology

